Abstract
LBA2 Clinical outcomes with perioperative nivolumab (NIVO) in patients (PTS) with resectable NSCLC from the phase III CheckMate 77T study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have